Results 101 to 110 of about 16,753 (223)
Vareniclina en el tratamiento del tabaquismo: efi cacia y seguridad en población general, psiquiátrica y drogodependiente [PDF]
Desde el año 2006 la vareniclina se está utilizando como tratamiento de primera elección para dejar de fumar. La mayoría de estudios publicados sobre efi cacia y seguridad de este producto se han hecho sobre muestras de fumadores sanos.
Ballbè Gibernau, Montse +6 more
core
Cigarette Use and Striatal Dopamine D2/3 Receptors: Possible Role in the Link between Smoking and Nicotine Dependence. [PDF]
BackgroundCigarette smoking induces dopamine release in the striatum, and smoking- or nicotine-induced ventral striatal dopamine release is correlated with nicotine dependence.
London, Edythe D +2 more
core +2 more sources
Varenicline-induced manic episode
Varenicline is a novel antismoking agent that reduces cravings and blocks pleasure of nicotine by serving as a partial agonist to the nicotinic receptor Varenicline has been associated with some important psychiatric adverseeffects for the patients with ...
Omer Gecici +2 more
doaj +1 more source
Smoking cessation and tobacco prevention in Indigenous populations [PDF]
This article systematically reviews 91 smoking cessation and tobacco prevention studies tailored for Indigenous populations around the world, with a particular focus on Aboriginal and Torres Strait Islander populations in Australia. We identified several
Adrian Esterman +9 more
core +1 more source
Varenicline: A review of the literature and place in therapy
Evidence regarding the health consequences of smoking is undeniable, yet 21% of the American population continues to smoke. In addition to behavioral modifications, first-line treatment options include nicotine replacement therapies and bupropion SR ...
Whitley HP, Moorman KL.
doaj
Vareniclina. Un paso más en la lucha contra el tabaquismo [PDF]
Recientemente la Food and Drugs Administration ha aprobado Vareniclina, fármaco para la deshabituación tabáquica que presenta un novedoso mecanismo de acción, agonismo parcial de receptores nicotínicos de acetilcolina a4ß2.Hemos revisado la farmacología,
Donat, Lucas +5 more
core
144 Nurses meet the challenge of helping high CVD risk smokers to quit with the help of varenicline in a preventive cardiology programme [PDF]
C.S. Jennings +7 more
openalex +1 more source
Introduction: The purpose of this study is to delineate anti-inflammatory and antioxidant potential of varenicline, a cigarette smoking cessation aid, on decreasing lipopolysaccharide (LPS)-elevated proinflammatory cytokines in RAW 264.7 murine ...
Elif Baris +2 more
doaj +1 more source

